This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
payments: Archive
Why Affirm's 38% YTD Drop Could Be a Golden Opportunity for Investors
by Kaibalya Pravo Dey
AFRM is developing debit products and exploring banking integrations to make its services part of customers' everyday spending.
MANegative Net Change VPositive Net Change PYPLNegative Net Change AFRMPositive Net Change
business-services fin-tech finance payments tech-stocks
Should You Buy Synchrony Stock After Wall Street Ups Earnings View?
by Kaibalya Pravo Dey
SYF's CareCredit platform is expanding rapidly, especially within the healthcare sector.
COFPositive Net Change AXPNegative Net Change SYFPositive Net Change
finance payments
AmEx Stock Trails S&P 500, Declines 21% YTD: Time to Buy or Cash Out?
by Kaibalya Pravo Dey
AXP's clients typically have higher incomes and strong credit scores, which helps minimize credit risks.
MANegative Net Change VPositive Net Change AXPNegative Net Change
credit-card finance payments
Mastercard vs. AmEx: Which Payments Giant Has More Room to Run?
by Kaibalya Pravo Dey
Compared to MA's more globally diversified business, AXP remains more exposed to domestic economic shifts.
MANegative Net Change AXPNegative Net Change
business-services finance payments
Visa Introduces New Services to Drive Innovation and Client Growth
by Zacks Equity Research
V launches a new set of services to empower businesses with innovative financial solutions that focus on boosting payment security and providing AI-driven Insights.
VPositive Net Change PAGSNo Net Change OPFINegative Net Change SEZLPositive Net Change
business-services finance payments
Clearway Energy (CWEN)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
CWENPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Information Services Group (III) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
IIINegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sky Harbour Group Corporation (SKYH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
SKYHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Groupon (GRPN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GRPNPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ADMANegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Is Visa Stock Worth Buying Now After a 24.4% Surge in 6 Months?
by Kaibalya Pravo Dey
Higher processed transactions, increased payment volumes and a continued rise in cross-border activity are boosting V.
MANegative Net Change VPositive Net Change AXPNegative Net Change
business-services finance payments
Should You Buy ANI Pharmaceuticals (ANIP) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ANIPPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Astronics Corporation (ATRO)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ATRONegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Affirm Partners With StockX to Offer Flexible Payments to U.S. Shoppers
by Zacks Equity Research
AFRM provides StockX shoppers access to flexible payment plans in a bid to expand its merchant partner network.
GRMNNegative Net Change NVMIPositive Net Change SFIXPositive Net Change AFRMPositive Net Change
computers internet payments tech-stocks
Visa vs. Mastercard: Which Payments Giant Should You Buy Now?
by Kaibalya Pravo Dey
Visa operates with lower financial leverage than Mastercard, indicating a more conservative debt management approach.
MANegative Net Change VPositive Net Change AXPNegative Net Change
business-services finance payments
WK Kellogg (KLG) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
KLGNo Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Evertec (EVTC) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
EVTCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Synchrony Declines 16.1% in a Month: Is the Stock a Buy on the Dip?
by Kaibalya Pravo Dey
SYF's net charge-off rate is expected to decline in 2025, particularly in the second half of the year.
COFPositive Net Change AXPNegative Net Change SYFPositive Net Change
finance payments
EverQuote (EVER) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
EVERPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
5 Mobile Payment Stocks to Buy Now and Wait for Long-Term Gains
by Nalak Das
Five mobile payment stocks have strong growth potential for 2025. These are: AFRM, PYPL, AXP, JPM, V.
JPMPositive Net Change VPositive Net Change AXPNegative Net Change PYPLNegative Net Change AFRMPositive Net Change
mobile payments
How to Play Affirm Stock After the Morgan Stanley TMT Conference?
by Kaibalya Pravo Dey
AFRM is evolving beyond BNPL, with international expansion, product innovation, and a focus on profitability, positioning it for long-term growth.
MANegative Net Change VPositive Net Change PYPLNegative Net Change AFRMPositive Net Change
business-services finance payments
AmEx Sweetens the Deal With a Dividend Hike: Buy, Hold or Sell?
by Kaibalya Pravo Dey
By balancing financial discipline, premium offerings and strategic customer engagement, AXP appears well-equipped to sustain its growth trajectory.
MANegative Net Change AXPNegative Net Change SYFPositive Net Change
dividend dividend-yield finance payments
Affirm's Partnership With Stitch Fix is Crucial: Here's Why
by Zacks Equity Research
The partnership adds Stitch Fix to AFRM's global network of more than 337,000 merchants.
VPositive Net Change PYPLNegative Net Change SFIXPositive Net Change AFRMPositive Net Change
business-services finance payments
Weekly Option Windfall: Call Option Spread 'Affirmed' With a 43% Return Potential
by Bryan Hayes
Even if AFRM loses 10% from our entry, this option spread will produce a 42.9% return.
AFRMPositive Net Change
artificial-intelligence cloud-computing consumer-discretionary earnings fin-tech options payments software tech-stocks
After Golden Cross, Option Care (OPCH)'s Technical Outlook is Bright
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
OPCHNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines